Brief: InDex Pharma Gets New Patent For Cobitolimod Granted In U.S.

Flerie AB

09/11/2021 14:47

Nov 9 (Reuters) - InDex Pharmaceuticals Holding AB
 INDEX.ST :
    * INDEX PHARMACEUTICALS GETS NEW PATENT FOR COBITOLIMOD
GRANTED IN
US
    * INDEX PHARMACEUTICALS - PATENT WILL PROVIDE EXCLUSIVITY
PERIOD
UNTIL MAY 2038, WITH POSSIBILITY OF UP TO 5 YEARS TERM EXTENSION
AFTER MARKET APPROVAL
    * INDEX PHARMACEUTICALS - PATENT PROVIDES PROTECTION FOR USE
OF
CERTAIN DOSAGE REGIMENS OF COBITOLIMOD FOR TREATING INFLAMMATORY
BOWEL DISEASE

Source text for Eikon:  ID:nPn3Djp3Pa 
Further company coverage:  INDEX.ST 

 ((Reuters.Briefs@thomsonreuters.com;))